Mark Busch

Mark Busch, PhD brings over twenty years of experience in QA/QC, analytical, and regulatory support of GXP operations. Prior to joining Medicines360, he held a number of senior level Quality positions including VP of QA at NeurogesX. He also brings with him extensive experience as a senior Quality leader from his tenure at firms like Geron, VaxGen, InterMune, and Scios. He also led a successful pharmaceutical consulting business.

As a Quality executive, Dr. Busch has expertise in developing and implementing Quality systems, SOPs, and audits, as well as reviews of manufacturing and technical documentation for compliance assessment and remediation. In addition, Dr. Busch has published several peer reviewed articles.

Dr. Busch holds a PhD in Biological Chemistry from Indiana University and performed post-doctoral research at Carnegie Mellon University.